AP2219A - Intermediate and process for preparing of beta-anomer enriched 2'deoxy, 2',2'-difluoro-D-ribofuranosyl nucleosides. - Google Patents
Intermediate and process for preparing of beta-anomer enriched 2'deoxy, 2',2'-difluoro-D-ribofuranosyl nucleosides.Info
- Publication number
- AP2219A AP2219A AP2007004098A AP2007004098A AP2219A AP 2219 A AP2219 A AP 2219A AP 2007004098 A AP2007004098 A AP 2007004098A AP 2007004098 A AP2007004098 A AP 2007004098A AP 2219 A AP2219 A AP 2219A
- Authority
- AP
- ARIPO
- Prior art keywords
- deoxy
- difluoro
- beta
- preparing
- anomer enriched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN472DE2005 | 2005-03-04 | ||
PCT/IN2005/000322 WO2006092808A1 (fr) | 2005-03-04 | 2005-09-23 | Intermediaire et procede de preparation de 21desoxy, 21, 21-difluoro-d-ribofuranosyl nucleosides enrichis en anomeres beta |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2007004098A0 AP2007004098A0 (en) | 2007-08-31 |
AP2219A true AP2219A (en) | 2011-03-22 |
Family
ID=35457749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2007004098A AP2219A (en) | 2005-03-04 | 2005-09-23 | Intermediate and process for preparing of beta-anomer enriched 2'deoxy, 2',2'-difluoro-D-ribofuranosyl nucleosides. |
Country Status (24)
Country | Link |
---|---|
US (2) | US7235647B2 (fr) |
EP (1) | EP1853616B1 (fr) |
JP (1) | JP2008531680A (fr) |
KR (1) | KR20070112774A (fr) |
CN (1) | CN101203524B (fr) |
AP (1) | AP2219A (fr) |
AR (1) | AR052860A1 (fr) |
AT (1) | ATE458743T1 (fr) |
AU (1) | AU2005328519B2 (fr) |
BR (1) | BRPI0520050A2 (fr) |
CA (1) | CA2598895A1 (fr) |
CL (1) | CL2005003456A1 (fr) |
DE (1) | DE602005019626D1 (fr) |
EA (1) | EA011558B1 (fr) |
ES (1) | ES2341663T3 (fr) |
GE (1) | GEP20094822B (fr) |
IL (1) | IL184957A (fr) |
MX (1) | MX2007010316A (fr) |
MY (1) | MY141378A (fr) |
NZ (1) | NZ560735A (fr) |
TW (1) | TWI333493B (fr) |
UA (1) | UA88940C2 (fr) |
WO (1) | WO2006092808A1 (fr) |
ZA (1) | ZA200706392B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070112774A (ko) * | 2005-03-04 | 2007-11-27 | 다브르 파마 리미티드 | 베타―아노머가 많은21데옥시,21,21-디플루오로-d-리보푸라노실뉴클레오시드의 제조를 위한 중간체 및 제조 방법 |
WO2008026222A2 (fr) * | 2006-08-28 | 2008-03-06 | Shilpa Medicare Ltd | Procédé et produits intermédiaires de 2,2'-difluoronucléosides |
KR100846143B1 (ko) | 2007-02-28 | 2008-07-14 | (주) 유일팜테크 | 2'-데옥시-2',2'-디플루오로시티딘의 전구체 및 그의제조방법 |
CN102093451A (zh) * | 2009-12-12 | 2011-06-15 | 上海华理生物医药有限公司 | 一种制备吉西他滨中间体的方法 |
CN102153601A (zh) * | 2011-02-26 | 2011-08-17 | 湖南欧亚生物有限公司 | 一种高选择性的制备盐酸吉西他滨以及其中间体的方法 |
CN102603838B (zh) * | 2012-02-14 | 2015-02-18 | 江苏八巨药业有限公司 | 一种制备吉西他滨盐酸盐的方法 |
CN103232508A (zh) * | 2012-05-22 | 2013-08-07 | 湖北一半天制药有限公司 | 工业化盐酸吉西他滨的合成方法 |
CN110088076A (zh) | 2016-12-28 | 2019-08-02 | 株式会社钟化 | 醇化合物的制造方法 |
CN110831605A (zh) | 2017-04-26 | 2020-02-21 | 托马斯·I.·卡尔曼 | 多靶标的核苷衍生物 |
CN107200757B (zh) * | 2017-06-29 | 2020-06-02 | 上海泓博智源医药股份有限公司 | 一种桥环氟代酯及其制备方法和应用 |
CN110511258A (zh) * | 2018-05-21 | 2019-11-29 | 中国科学院上海药物研究所 | 一种胞嘧啶核苷的制备方法 |
CN109796506A (zh) * | 2019-01-28 | 2019-05-24 | 江苏八巨药业有限公司 | 一种吉西他滨关键中间体的制备方法 |
CN111909229B (zh) * | 2020-08-12 | 2023-05-05 | 福建瑞博奥科技有限公司 | 一种β-烟酰胺核糖氯化物的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256798A (en) * | 1992-06-22 | 1993-10-26 | Eli Lilly And Company | Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
EP0577303A1 (fr) * | 1992-06-22 | 1994-01-05 | Eli Lilly And Company | Procédé de glycosylation steréoséléctive |
US5401861A (en) * | 1992-06-22 | 1995-03-28 | Eli Lilly And Company | Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
EP0184365B1 (fr) * | 1984-12-04 | 1993-08-04 | Eli Lilly And Company | Traitement de tumeurs chez les mammifères |
ZA859008B (en) * | 1984-12-04 | 1987-07-29 | Lilly Co Eli | The treatment of tumors in mammals |
US4814438A (en) * | 1986-12-24 | 1989-03-21 | Eli Lilly And Company | Immunoglobulin conjugates of 2',2'-difluronucleosides |
US4994558A (en) * | 1986-12-24 | 1991-02-19 | Eli Lilly And Company | Immunoglobulin conjugates |
US5223608A (en) * | 1987-08-28 | 1993-06-29 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
US5644043A (en) * | 1988-02-16 | 1997-07-01 | Eli Lilly And Company | 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates |
US5401838A (en) * | 1992-06-22 | 1995-03-28 | Eli Lilly And Company | Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
US5606048A (en) * | 1992-06-22 | 1997-02-25 | Eli Lilly And Company | Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
US5594124A (en) * | 1992-06-22 | 1997-01-14 | Eli Lilly And Company | Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof |
FI932871A (fi) * | 1992-06-22 | 1993-12-23 | Lilly Co Eli | Stereoselektiv anjonglykosylationsprocess |
US5371210A (en) * | 1992-06-22 | 1994-12-06 | Eli Lilly And Company | Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
US5426183A (en) * | 1992-06-22 | 1995-06-20 | Eli Lilly And Company | Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
US5821357A (en) * | 1992-06-22 | 1998-10-13 | Eli Lilly And Company | Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides |
YU43193A (sh) * | 1992-06-22 | 1997-01-08 | Eli Lilly And Company | 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi |
KR100252451B1 (ko) * | 1992-09-01 | 2000-04-15 | 피터 지. 스트링거 | 뉴클레오사이드의아노머화방법 |
US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
US5521294A (en) * | 1995-01-18 | 1996-05-28 | Eli Lilly And Company | 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides |
US5559222A (en) * | 1995-02-03 | 1996-09-24 | Eli Lilly And Company | Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
FR2808797A1 (fr) * | 2000-05-09 | 2001-11-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments |
AU2005320374B2 (en) * | 2004-12-30 | 2009-01-08 | Hanmi Science Co., Ltd. | Method for the preparation of 2'-deoxy-2',2'-difluorocytidine |
KR20070112774A (ko) * | 2005-03-04 | 2007-11-27 | 다브르 파마 리미티드 | 베타―아노머가 많은21데옥시,21,21-디플루오로-d-리보푸라노실뉴클레오시드의 제조를 위한 중간체 및 제조 방법 |
-
2005
- 2005-09-23 KR KR1020077018233A patent/KR20070112774A/ko not_active Application Discontinuation
- 2005-09-23 DE DE602005019626T patent/DE602005019626D1/de active Active
- 2005-09-23 WO PCT/IN2005/000322 patent/WO2006092808A1/fr active Application Filing
- 2005-09-23 ES ES05794951T patent/ES2341663T3/es active Active
- 2005-09-23 UA UAA200709045A patent/UA88940C2/ru unknown
- 2005-09-23 EP EP05794951A patent/EP1853616B1/fr active Active
- 2005-09-23 NZ NZ560735A patent/NZ560735A/en not_active IP Right Cessation
- 2005-09-23 CA CA002598895A patent/CA2598895A1/fr not_active Abandoned
- 2005-09-23 AU AU2005328519A patent/AU2005328519B2/en not_active Ceased
- 2005-09-23 EA EA200701889A patent/EA011558B1/ru not_active IP Right Cessation
- 2005-09-23 MX MX2007010316A patent/MX2007010316A/es active IP Right Grant
- 2005-09-23 BR BRPI0520050-4A patent/BRPI0520050A2/pt not_active IP Right Cessation
- 2005-09-23 AT AT05794951T patent/ATE458743T1/de not_active IP Right Cessation
- 2005-09-23 CN CN200580049120XA patent/CN101203524B/zh not_active Expired - Fee Related
- 2005-09-23 AP AP2007004098A patent/AP2219A/xx active
- 2005-09-23 JP JP2007557679A patent/JP2008531680A/ja active Pending
- 2005-09-23 GE GEAP200510300A patent/GEP20094822B/en unknown
- 2005-12-28 CL CL200503456A patent/CL2005003456A1/es unknown
- 2005-12-28 MY MYPI20056213A patent/MY141378A/en unknown
- 2005-12-29 AR ARP050105638A patent/AR052860A1/es not_active Application Discontinuation
-
2006
- 2006-01-13 US US11/332,830 patent/US7235647B2/en not_active Expired - Fee Related
- 2006-02-15 TW TW095105122A patent/TWI333493B/zh active
-
2007
- 2007-02-26 US US11/678,927 patent/US20070208170A1/en not_active Abandoned
- 2007-07-31 IL IL184957A patent/IL184957A/en not_active IP Right Cessation
- 2007-08-01 ZA ZA200706392A patent/ZA200706392B/xx unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256798A (en) * | 1992-06-22 | 1993-10-26 | Eli Lilly And Company | Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
EP0577303A1 (fr) * | 1992-06-22 | 1994-01-05 | Eli Lilly And Company | Procédé de glycosylation steréoséléctive |
US5401861A (en) * | 1992-06-22 | 1995-03-28 | Eli Lilly And Company | Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
Also Published As
Publication number | Publication date |
---|---|
AU2005328519B2 (en) | 2012-03-01 |
MY141378A (en) | 2010-04-30 |
CL2005003456A1 (es) | 2008-05-02 |
UA88940C2 (ru) | 2009-12-10 |
EP1853616B1 (fr) | 2010-02-24 |
ES2341663T3 (es) | 2010-06-24 |
EA011558B1 (ru) | 2009-04-28 |
GEP20094822B (en) | 2009-11-10 |
NZ560735A (en) | 2009-07-31 |
BRPI0520050A2 (pt) | 2009-11-17 |
AU2005328519A1 (en) | 2006-09-08 |
CN101203524B (zh) | 2011-06-15 |
US20070208170A1 (en) | 2007-09-06 |
IL184957A0 (en) | 2007-12-03 |
CN101203524A (zh) | 2008-06-18 |
KR20070112774A (ko) | 2007-11-27 |
MX2007010316A (es) | 2008-02-19 |
AR052860A1 (es) | 2007-04-04 |
TWI333493B (en) | 2010-11-21 |
US7235647B2 (en) | 2007-06-26 |
WO2006092808A1 (fr) | 2006-09-08 |
TW200643027A (en) | 2006-12-16 |
EA200701889A1 (ru) | 2008-02-28 |
IL184957A (en) | 2011-06-30 |
CA2598895A1 (fr) | 2006-09-08 |
AP2007004098A0 (en) | 2007-08-31 |
ZA200706392B (en) | 2008-09-25 |
DE602005019626D1 (de) | 2010-04-08 |
ATE458743T1 (de) | 2010-03-15 |
JP2008531680A (ja) | 2008-08-14 |
US20060217547A1 (en) | 2006-09-28 |
EP1853616A1 (fr) | 2007-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2219A (en) | Intermediate and process for preparing of beta-anomer enriched 2'deoxy, 2',2'-difluoro-D-ribofuranosyl nucleosides. | |
HUE037069T2 (hu) | Eljárás nagy tisztaságú 2,4'-metiléndifenildiizocianát elõállítására | |
EP1746080A4 (fr) | 3,8-dihalogénopyrène substitué en position 1 et 6 et procédé servant à produire celui-ci | |
HK1078087A1 (en) | Process for the preparation of (s,s)-cis-2-benzhydryl-3- benzylaminoquinuclidine | |
SI1928882T1 (sl) | (s)-n-metilnaltrekson, postopek za njega sintezo in njega farmacevtska uporaba | |
IL189914A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them | |
EP1720556A4 (fr) | Nouveaux derives nucleosidiques de 2'-c-methyle | |
IL186523A0 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
ZA200702523B (en) | Process for the purification of 1,4-butanediol | |
IL181810A0 (en) | Compositions containing uridine, and methods utilizing same | |
IL176420A0 (en) | Process for the manufacture of 2,3-dichloropyridine | |
EP1802314A4 (fr) | Compositions contenant une uridine et leurs procedes d'utilisation | |
EP1808225A4 (fr) | Produit d'encapsulation, procédé servant à produire celui-ci et composition d'encre | |
IL165012A0 (en) | (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor | |
SI2020410T1 (sl) | Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba | |
AU2003257786A1 (en) | Process for the preparation of 4, 1', 6'-trichloro-4, 1', 6'-trideoxygalactosucrose | |
HUP0401523A2 (en) | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them | |
IL181691A0 (en) | Method for the preparation of 2'-deoxy-2',2'-difluorocytidine | |
IL190596A0 (en) | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
HK1216432A1 (zh) | 製備 -二氧戊環核苷的方法 | |
EP1911812A4 (fr) | Procédé de production de mélanine, mélanine produite par le procédé, film fonctionnel contenant la mélanine, et procédé de production du film | |
EP1883628A4 (fr) | Procede ameliore de preparation de 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine | |
EP1731510A4 (fr) | Procédé servant à produire du n,n'-carbonyldiimidazole | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. |